European Animal Research Association (EARA) ARSAL Symposium Thursday 23 rd May 2015 Animal Research: Time to Talk
|
|
- Jade Arnold
- 6 years ago
- Views:
Transcription
1 European Animal Research Association (EARA) ARSAL Symposium Thursday 23 rd May 2015 Animal Research: Time to Talk
2 EARA Board 2015 Our Articles of Association specify that the board must maintain a 50% profit and 50% non-profit membership. All members of EARA can vote at the General Assembly and stand for the Board. It is one vote per organisation, whether they be a University, a Publically Funded Research Institution, or a Global Pharmaceutical company. EARA Board Membership: Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) Associazione Italiana per le Scienze degli Animali da Laboratorio (AISAL) Covance The European Federation of Pharmaceutical Industries and Associations (EFPIA) (ex-officio member) Groupe Interprofessionnel de Réflexion et de Communication sur la Recherche (GIRCOR) GSK Harlan Mario Negri Institute Marshall Bio Services Sanofi Group Stichting Informatie Dierproeven (SID) Understanding Animal Research (UAR)
3 2015 EARA Membership Commercial Organisations Abbvie AZ Bayer Boehringer Ingelheim Covance Ellegard Mini Pigs Farmindustria GSK Harlan Harteleust JnJ LPT Merck Marshall Bio Novartis Noveprim RTC SANOFI Group SNBL Non-for-Profit Organisations Association for Assessment and Accreditation of Laboratory Animal Care (AALAC) Associazione Italiana per le Scienze degli Animali da Laboratorio (AISAL) Italy Basle Declaration - Switzerland Belgian Laboratory Animal Council (BCLAS) - Belgium Federation of European Neurological Societies (FENS) Groupe Interprofessionnel de Réflexion et de Communication sur la Recherche (GIRCOR) France Hannover Medical Schools in progress Helmholtz Centrum Munich in progress INFRAFRONTIER GMBH in progress International Council for Laboratory Animal Science (ICLAS) Mario Negri Institute - Italy Max Plank Society in progress Max Delbrück Center for Molecular Medicine Germany Stichting Informatie Dierproeven (SID) Holland Understanding Animal Research (UAR) UK
4 Purpose of EARA Facilitate: the establishment of local animal research advocacy groups and networks in countries where they don t exist Maintain and improve: a high level of public acceptance of animal research for human and animal medical benefits, through a variety of communications means, and to increase awareness of work to produce alternatives to animal models Lead: pan-european Transport initiatives to counter pressure on the lab animals supply chain and the license to use laboratory animals in research Create: a favourable climate for research using laboratory animals in Europe, through influencing national and EU decision makers
5 Current Challenges To Animal Research in the EU (1) Policy -> European Citizens Initiative to Stop Vivisection (submitted March 2015) Possible revision of EU Directive 2010/63 on the protection of animals used for scientific purposes (2) Communications > Absence in many countries of an intelligent narrative to the public and decision makers on the benefits of animal research and progress in developing alternatives (3) Supply Chain-> Transport of Laboratory Animals, Running out of options, Air France, UK transport boycott (4) Scientific -> Growing challenge to Basic Science Research, AALAC v PETA accreditation; Dogs as second model in Toxicology studies. (5) Germany/Italy > Crisis countries with little public advocacy
6 (1) Policy: European Citizens Initiative to Stop Vivisection
7 Breakdown of Signatures by Numbers 800, , , , , , , ,000 0 Italy Germany France Spain Poland Hungary Slovenia
8
9 European Life Sciences Sector Statement
10 Public Hearing: European Commission May 11 th Brussels
11 (2) Communications: Pan European Advertising Campaign Against Animal Testing (research)
12 Undercover Infiltration at the Max Planck Institute Tubingen Germany
13 (3) Supply Chain: Global Campaign to halt Laboratory Animal Transport
14 Research Animals transport boycott
15 4) Challenges on the Scientific level
16 (5) National Problems: Germany and Italy
17 WHY COMMUNICATE?
18 Because they are and they are good
19 Fact into Fiction
20
21 Washington DC Metro: PETA Poster Campaign
22 Communicating on Animal Research: How?
23 Getting our messages across
24 Factual Information
25 Positive Media coverage
26 Pro-Test and Progress
27 Noble Prizes 2014 "It is an incontrovertible fact that if we want to make progress in basic areas of medicine and biology we are going to have to use animals
28 Improving Openness Animal Research Web Statements INSTITUTION Germany Italy UK Non-profit and learned societies 29% 9% 56% Profit Sector 10% 20% 87% Universities 11% 16% 89% Patient Groups/Medical Research Charities 0% 3% 45%
29 Pushing the door open further
30 Concordat on Openness and Animal Research Commitment 1: We will be clear about when, how and why we use animals in research Commitment 2: We will enhance our communications with the media and the public about our research using animals Commitment 3: We will be proactive in providing opportunities for the public to find out about research using animals Commitment 4: We will report on progress annually and Share our experiences
31 The Concordat
32 Thank You Any questions?
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 199 PATIENT GROUPS with an interest in RARE DISEASES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 199 PATIENT GROUPS with an interest in RARE DISEASES PUBLISHED MAY 2016 Dans notre domaine de maladies rares où des efforts ont été faits pour
More informationTHE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (SPANISH EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (SPANISH EDITION) Feedback from 108 Spanish patient groups PUBLISHED MAY 2016 Nuevos tratamientos con precios que impidan el acceso para
More informationTHE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 118 PATIENT GROUPS with an interest in RESPIRATORY CONDTIONS
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 118 PATIENT GROUPS with an interest in RESPIRATORY CONDTIONS PUBLISHED OCTOBER 2016 [Question to respondents: Which companies have the best record
More informationThe Innovative Medicines Initiative
The Innovative Medicines Initiative Innovative funding for biotechs & SMEs in Europe Pierre Meulien, IMI Executive Director BIO-Europe Conference, Copenhagen 06.11.2018 IMI Europe s partnership for health
More informationTHE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (NORDIC EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (NORDIC EDITION) Feedback from 147 Nordic patient groups PUBLISHED JUNE 2016 Syöpälääkkeiden kehitys on ollut hyvä, ja yhä useammat paranevat.
More informationPharmaceutical lobbying
FREE ARTICLE Pharmaceutical lobbying Author: Magdalena Nizińska July 2012 A successful market entry of a new medicine requires on one hand obeying the registration procedures, and on the other plenty of
More informationwithin April Organised by the With
EFGCP Multi-Stakeholder Workshop & Discussion on How to Ensure Optimal Ethical Review within the New Clinical Trials Regulation? Wheree do we currently stand with the implementation in different Member
More informationTHE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EUROPE EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EUROPE EDITION) Feedback from 797 patient groups in Europe PUBLISHED APRIL 2016 The perception [of pharma] has changed in the last years,
More informationThe FMD Pack Coding, Sharing and Transition
The FMD Pack Coding, Sharing and Transition Ask the expert Joan Cahill & Grant Courtney April 2017 Introduction Joan Cahill Director, Pfizer Packaging & Delivery Systems Member EFPIA Supply Chain Working
More informationHealth and Social Care Committee
Health and Social Care Committee Impact of a No-deal Brexit on health and social care inquiry submission Impact of a No-deal Brexit on animal science used for the development of human and veterinary medicines
More informationFrance Pharma RepTrak 2017
France Pharma RepTrak 2017 The World s Most Reputable Pharmaceutical Companies in France Olivier Forlini, Director Reputation Institute France June 2017 1 Why Measure Reputation? The success of your company
More informationTHE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (GERMAN EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (GERMAN EDITION) Feedback from 60 German patient groups PUBLISHED JUNE 2016 Die neuen, extrem hohen Hepatitis-C- Medikamenten-Preise haben
More informationEAS-IAAPA. «Entertainment and The Digital Industry» From here to
EAS-IAAPA «Entertainment and The Digital Industry» From here to 2020... 2 VISION MARKETING WILL NEVER BE THE SAME ANYMORE. 3 Source: Financial Times The ad model is changing dramatically 4 From a passive
More informationWaste prevention in Europe. European Environment Agency
Waste prevention in Europe Özgür Saki European Environment Agency The European Environment Agency An EU institution situated in Copenhagen since 1994 Provides the information necessary to enable policy
More informationJoint Statement on the Innovative Medicines Initiative
Joint Statement on the Innovative Medicines Initiative FOR IMMEDIATE RELEASE Brussels, 6 July 2010 The Innovative Medicines Joint Technology Initiative (IMI) was launched in May 2007. From the beginning,
More informationUPDATE ON COMBACTE STATUS AND ACTIVITIES
UPDATE ON COMBACTE STATUS AND ACTIVITIES MARC BONTEN APRIL 24TH, 2017 Program 18:30-18:50 Update on COMBACTE status and activities Prof. Dr. Marc Bonten (UMC Utrecht) 18:50-19:10 Studies on Clostridium
More informationCAOBISCO S APPROACH TO SUSTAINABILITY. ELC, May 2016, Brussels
CAOBISCO S APPROACH TO SUSTAINABILITY ELC, May 2016, Brussels In this presentation ABOUT CAOBISCO ABOUT CAOBISCO S APPROACH TO SUSTAINABILITY SOME CASE STUDIES QUESTIONS AND ANSWERS About CAOBISCO: Membership
More informationESF Ex-Post evaluation
ESF 2007-2013 Ex-Post evaluation Fields marked with * are mandatory. Open public consultation Questionnaire Please consult the background document as it provides useful information on the European Social
More informationCar advertising in Europe
Car advertising in Europe Jos Dings, Director, T&E 28 June 2007 T&E membership Austria, Belgium, Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Italy, Netherlands, Norway, Poland,
More informationSUCCESSFUL BRANDS: LATVIA ESTONIA CROATIA GERMANY UNITED KINGDOM BOSNIA-HERZEGOVINA BULGARIA MACEDONIA SERBIA CZECH REPUBLIC SLOVAKIA FRANCE AUSTRIA
ACCESS TO SUCCESS SUCCESSFUL BRANDS: CROATIA ESTONIA LATVIA BOSNIA-HERZEGOVINA BULGARIA MACEDONIA SERBIA GERMANY UNITED KINGDOM SLOVAKIA CZECH REPUBLIC FRANCE HUNGARY AUSTRIA ITALY ACCESS TO OUR MARKETS
More informationPublic consultation on pharmaceuticals in the environment
Contribution ID: 1bdef173-cd9f-44e0-a6bb-b9fef643f15d Date: 16/02/2018 12:07:54 Public consultation on pharmaceuticals in the environment Fields marked with * are mandatory. About this consultation This
More informationThe European Medical Technology Industry. in figures / 2018
The European Medical Technology Industry in figures / 2018 Table of contents What is Medical Technology? 4 Innovation 10 Employment 14 Companies 18 Expenditure on Medical Technology 20 MedTech Market in
More informationOTC, Self-Care Medical Devices, Food Supplements and Herbal Products: Market trends and Opportunities in Germany and Central Europe
OTC, Self-Care Medical Devices, Food Supplements and Herbal Products: Market trends and Opportunities in Germany and Central Europe Dr. Frank Wartenberg President Central Europe, GM Germany Copyright 2017
More informationFacts about the European Parliament Elections 2009
European Parliament Elections BRIEFING PAPER 1 Facts about the European Parliament Elections 2009 When are the Elections? The European Parliament Elections take place over a period of 4 days from 4 to
More information3Rs: Replace, Reduce, Refine Minimising Impact & Reducing Numbers
COMPUTER SIMULATION IS INCREASINGLY RELIABLE REDUCTION Data derived from computer simulation enables a more efficient use of animal models. Also, as the quality of information increases, the best compounds
More informationPublic - Private Partnerships in Europe and ENCePP Initiative
Public - Private Partnerships in Europe and ENCePP Initiative Henry Fitt Section Head, Co-ordination & Networking, Pharmacovigilance and Risk Management European Medicines Agency 22nd Annual EuroMeeting
More informationRole of an OIE Reference Laboratory Trichinellosis. Edoardo Pozio Istituto Superiore di Sanità Rome, Italy
Role of an OIE Reference Laboratory Trichinellosis Edoardo Pozio Istituto Superiore di Sanità Rome, Italy Historical background The OIE Reference Laboratory for Trichinellosis was appointed at the Istituto
More informationProduct Overview: Global Life Sciences Survey. One Firm. Complete Solutions.
Product Overview: Global Life Sciences Survey One Firm. Complete Solutions. Unmatched Life Sciences Expertise 59 Reporting Countries 812 Participating Organizations 1,900 Unique Jobs Surveyed 390 Thousand
More informationCutting Red Tape The Member State point of view. Presentation by Hilde Van de Velde Bruges March 2010
Cutting Red Tape The Member State point of view Presentation by Hilde Van de Velde Bruges March 2010 The Action Programme created a momentum for reducing administrative burdens and inspired MS to launch
More informationwithin April Organised by the
EFGCP Multi-Stakeholder Workshop &Discussion on How to Ensure Optimal Ethical Review within the New Clinical Trials Regulation? Wheree do we currently stand with the implementation in different Member
More informationThema: Maatschappelijke verantwoordelijkheid van de farmaceutische industrie: beschikbaarheid en betaalbaarheid van de toegang tot zorg
Thema: Maatschappelijke verantwoordelijkheid van de farmaceutische industrie: beschikbaarheid en betaalbaarheid van de toegang tot zorg Farma uitgedaagd. Kunnen wij spreken van fair medicine? Carin Uyl-de
More informationThe nuclear scene in Europe: current reality and future trends
The nuclear scene in Europe: current reality and future trends Santiago San Antonio Director General of FORATOM UPM Summer Courses Madrid, 6 July 2009 FORATOM who we are? Brussels-based trade association
More informationA French Biotechnology company dedicated to the development and production of human endocrine cell lines. Innovation In Healthcare April 2012
A French Biotechnology company dedicated to the development and production of human endocrine cell lines Innovation In Healthcare 16-17 April 2012 1 French Biotechnology company Founded in S2 2004 in Paris
More informationPublic Services Online: how is Europe progressing? Web-based Survey on Electronic Public Services, Results October 2004 Brussels, February 2005
Public Services Online: how is Europe progressing? Web-based Survey on Electronic Public Services, Results October 2004 Brussels, February 2005 2005 Capgemini - All rights reserved - January 2005 1 Contents
More informationFEDERAL PUBLIC SERVICE DOMESTIC AFFAIRS EUROPEAN CITIZENS VOTE FOR THE EUROPEAN PARLIAMENT. ON THE 13th JUNE 2004 (+ LOGO INTERIEUR)
VERSION : 18 NOVEMBRE 2003 (page 1) DRAFT FOLDER 2004 EU CITIZENS - ENGLISH ------ FEDERAL PUBLIC SERVICE DOMESTIC AFFAIRS EUROPEAN CITIZENS VOTE FOR THE EUROPEAN PARLIAMENT ON THE 13th JUNE 2004 (+ LOGO
More informationAcurian on. Bolstering Clinical Trial Enrollment with Site Support Services It s All about Relationships
Acurian on Bolstering Clinical Trial Enrollment with Site Support Services It s All about Relationships Within the patient enrollment continuum, when a candidate for a clinical trial attends their First
More informationThe Innovative Medicines Initiative: Building new models of collaborative research across Europe
The Innovative Medicines Initiative: Building new models of collaborative research across Europe Elisabetta Vaudano IMI, Belgium www.imi.europa.eu What is IMI? An European Public-Private Partnership Focused
More informationInternational services
International services More options around the world technology delivering Click to turn page International services Contents Page DPD CLASSIC 4 DPD CLASSIC Europe and beyond by ground and air DPD EXPRESS
More informationHigh-Level Public Administration Conference For a Business-Friendly Public Administration Brussels, 29 October 2013
European Institute of Public Administration - Institut européen d administration publique High-Level Public Administration Conference For a Business-Friendly Public Administration Brussels, 29 October
More informationUpdate on the IMI2 Proposal to Build a Sustainable pan- European Paediatric Clinical Trials Network
Update on the IMI2 Proposal to Build a Sustainable pan- European Paediatric Clinical Trials Network William R Treem, M.D.;* Child Health Innovation and Leadership Department, Johnson and Johnson October
More informationStrategic vision of Pharma Market
Strategic vision of Pharma Market Evolution 2012-2016 ACIP Presentation, Paris January 30, 2013 Introduction This presentation draws strategic orientations for pharma companies considering the expected
More informationCAP CONTEXT INDICATORS
CAP CONTEXT INDICATORS 2014-2020 24. AGRICULTURAL TRAINING OF FARM MANAGERS 2017 update CONTEXT INDICATOR 24: AGRICULTURAL TRAINING OF FARM MANAGERS Learning by doing is still the main form of for the
More informationELARD Estonian presidency main aims and achievements President Kristiina Tammets
ELARD Estonian presidency main aims and achievements 2016-2017 President Kristiina Tammets Main aims of the Estonian presidency 2016/17, (Portuguese and Czech vice-presidencies) To defend the principles
More informationWhat do European and UK companies think of Brexit? A social media perspective
What do European and UK companies think of Brexit? A social media perspective Foreword If all goes according to plan the United Kingdom will leave the European Union on March 29th, 2019. This will herald
More informationGlobal In-Vitro Diagnostic Market Report
Global In-Vitro Diagnostic Market Report ----------------------------------------------------- 2013 Executive Summary The process of performing a diagnostic test outside of a living organism in an artificial
More informationTheme Sub-theme Quote / issue. Inconsistency and
Theme Sub-theme Quote / issue Inconsistency and ambiguity Problematic and contradictory use of the term "all". Abbvie's webpage describing their transparency policy says "AbbVie will submit a manuscript
More informationLSE Health Market Access Academy April 2018, London September 2018, London
LSE Health Market Access Academy 9 13 April 2018, London 10 14 September 2018, London In cooperation with the Boston Consulting Group Market Access Roundtable LSE Health Market Access Academy 2 The London
More informationPV CYCLE European association for the take-back and treatment of discarded PV Panels GRCJ- AGC Delegation Brussels
PV CYCLE European association for the take-back and treatment of discarded PV Panels GRCJ- AGC Delegation 19.11.2015 Brussels PV CYCLE 2014 AGENDA MISSION HISTORY LEGISLATION OUR SERVICES Collection: small
More informationOptions and Challenges for Ethical Assessment in the Clinical Trial Regulation Proposal
EFGCP Workshop on Options and Challenges for Ethical Assessment in the Clinical Trial Regulation Proposal Road Map Initiative for Clinical Research in Europe Husa President Hotel, Brussels, Belgium 7 &
More informationEuropean Union (EU) Falsified Medicines Directive
European Union (EU) Falsified Medicines Directive Mr. Mike Rose, Vice President, Supply Chain Visibility Johnson & Johnson 18 October 2017 GS1 2017 The Promise of Serialization EU Falsified Medicines Directive
More informationEurostat current work on resource-efficient circular economy Renato Marra Campanale
Eurostat current work on resource-efficient circular economy Renato Marra Campanale Renato.Marra-Campanale@ec.europa.eu Eurostat Unit E2 'Environmental statistics and accounts; sustainable development'
More informationThe Context in which we operate
Prof. Sergio Pecorelli Presidente Agenzia Italiana del Farmaco Rettore Università degli Studi di Brescia The Context in which we operate Limited Resources Population Ageing Healthcare rights One single
More informationJob Description for EIT Health Spain Communications Lead
Job Description for EIT Health Spain Communications Lead About EIT Health EIT Health is a network of best-in-class health innovators backed by the EU. We collaborate across borders to deliver new solutions
More informationprovides the most effective method of ensuring product security
28 Buenos Aires ETIF 2010 - International and ANVISA Traceability Requirements G. Rossi 2010 rev. 1.0 Supports anti-counterfeiting and public health Combats fraud and prevents reimbursement fraud Reduces
More informationBRADFORD JACOBS WORKING IN BELGIUM BELGIUM FINLAND FRANCE GERMANY GREECE HUNGARY IRELAND ITALY LUXEMBOURG MALTA
BELGIUM FINLAND FRANCE GERMANY GREECE HUNGARY IRELAND ITALY LUXEMBOURG MALTA NETHERLANDS NORWAY POLAND SERBIA SLOVAKIA SPAIN SWEDEN SWITZERLAND UK BRADFORD JACOBS WORKING IN BELGIUM Bradford Jacobs can
More informationwww.nonstop-devices.com OFFICES: LUXEMBOURG ZUG LONDON PORTSMOUTH PRAGUE MUNICH Our own internal Quality Assurance function Continual professional development for all our employees, ensuring you liaise
More informationFINLAND RESULTS AND PAN-EUROPEAN COMPARISONS Alison Fennah, VP Research and Marketing, IAB Europe. Helsinki, 20 th September 2012
FINLAND RESULTS AND PAN-EUROPEAN COMPARISONS Alison Fennah, VP Research and Marketing, IAB Europe Helsinki, 20 th September 2012 Presentation Agenda 1. Introduction Background Coverage and Methodology
More informationWell-being in regions: Building more coherent policies for a better growth model
Liv i væksten Well-being in regions: Building more coherent policies for a better growth model Joaquim Oliveira Martins Head of the OECD Regional Development Policy Division Monica Brezzi Head of the Regional
More informationSafeSciMET. European Modular Education and Training Programme in Safety Sciences for Medicines
SafeSciMET European Modular Education and Training Programme in Safety Sciences for Medicines What patients need What Europe needs Rapid exploitation of insights in disease mechanisms for introduction
More informationAudits PDO/PGI/TSG Examples of Good Practices. Johannes Kern DG SANTE/FVO Unit F4.3
Audits PDO/PGI/TSG Examples of Good Practices Johannes Kern DG SANTE/FVO Unit F4.3 Overview (17) DG SANTE/FVO (5) Background Audits PDO/PGI/TSG (4) Lessons Learned and Good Practices (5) 2 DG Sante Food
More informationBRADFORD JACOBS WORKING IN THE CZECH REPUBLIC BELGIUM FINLAND FRANCE GERMANY GREECE HUNGARY IRELAND ITALY LUXEMBOURG MALTA
BELGIUM FINLAND FRANCE GERMANY GREECE HUNGARY IRELAND ITALY LUXEMBOURG MALTA NETHERLANDS NORWAY POLAND SERBIA SLOVAKIA SPAIN SWEDEN SWITZERLAND UK BRADFORD JACOBS WORKING IN THE CZECH REPUBLIC Bradford
More informationExperts Meeting. on Organ Donation and Transplantation. Action Plan March Summary report
EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C6 - Health Law and International Experts Meeting on Organ Donation and Transplantation Action
More informationIAB Europe AdEx Benchmark study H November 2016
IAB Europe AdEx Benchmark study H1 2016 November 2016 The data and charts shown in this report cannot be used without the expressed permission of IAB Europe and IHS Markit A meta analysis of online ad
More informationBRADFORD JACOBS WORKING IN SERBIA BELGIUM FINLAND FRANCE GERMANY GREECE HUNGARY IRELAND ITALY LUXEMBOURG MALTA
BELGIUM FINLAND FRANCE GERMANY GREECE HUNGARY IRELAND ITALY LUXEMBOURG MALTA NETHERLANDS NORWAY POLAND SERBIA SLOVAKIA SPAIN SWEDEN SWITZERLAND UK BRADFORD JACOBS WORKING IN SERBIA Bradford Jacobs can
More informationTRAINING COURSE ON ANIMAL WELFARE CONCERNING FARMING OF PIGS
TRAINING COURSE ON ANIMAL WELFARE CONCERNING FARMING OF PIGS Service Contract N 2010 9614 «EAHC/2010/BTSF/06» Author: Barbara Alessandrini 25-28 September 2012, Pescara, Italy www.sancotraining.izs.it
More informationEuropean Pharmaceutical Policy: Access for Patients or Improving Competitiveness
European Pharmaceutical Policy: Access for Patients or Improving Competitiveness The s Vision Dr Stefaan Van der Spiegel Policy Officer, Unit F5 DG Enterprise and Industry Study day OSE / RIZIV-INAMI Brussels,
More informationRethinking E-Government Services
Rethinking E-Government Services Session 3: Serving Citizens Becoming User-focused in the Provision of E-Government Services OECD-India meeting 4 December 2009 New Delhi, India Yih-Jeou Wang Head of Unit
More informationTaking the world s land
Taking the world s land Europe s overconsumption of resources and its impacts on people and the environment November 2013 Friends of the Earth Europe asbl Rue d Edimbourg 26 1050 Brussels Belgium Tel.
More informationPurification Strategy for Antibodies in partnership with Mannheim University of Applied Sciences
Chromatography Purification Strategy for Antibodies in partnership with Mannheim University of Applied Sciences Putting theory into practice In today s evolving workplace, it is vital to understand why
More informationAccomplishment and recommendations of standardization
Accomplishment and recommendations of standardization Dr Ed Suttie CONTENT 1. Task 2.1: Buildings Code, EPBD analysis and standardization 2. Deliverable 2.1 Assessment of national building codes, EPBD
More informationNext Generation of Electronic Translational Safety NexGETS. Francois Pognan & Thomas Steger-Hartman IMI webinar
Next Generation of Electronic Translational Safety NexGETS Francois Pognan & Thomas Steger-Hartman 18.04.2016 IMI webinar Objectives of the full project Development of an infrastructure for preclinical
More informationCOMMISSION STAFF WORKING DOCUMENT IMPACT ASSESSMENT. Accompanying the document. Proposal for a Council Regulation
EUROPEAN COMMISSION Brussels, 11.1.2018 SWD(2018) 6 final PART 3/4 COMMISSION STAFF WORKING DOCUMENT IMPACT ASSESSMENT Accompanying the document Proposal for a Council Regulation on establishing the European
More informationFRAMEWORK CONVENTION ON CLIMATE CHANGE - Secretariat CONVENTION - CADRE SUR LES CHANGEMENTS CLIMATIQUES - Secrétariat KEY GHG DATA
UNITED NATIONS NATIONS UNIES FRAMEWORK CONVENTION ON CLIMATE CHANGE - Secretariat CONVENTION - CADRE SUR LES CHANGEMENTS CLIMATIQUES - Secrétariat KEY GHG DATA Greenhouse Gas Emissions Data for 1990 2003
More informationCore projects and scientific studies as background for the NREAPs. 9th Inter-Parliamentary Meeting on Renewable Energy and Energy Efficiency
Core projects and scientific studies as background for the NREAPs 9th Inter-Parliamentary Meeting on Renewable Energy and Energy Efficiency Brussels, 18.11.2009 Mario Ragwitz Fraunhofer Institute Systems
More informationFacts&figures of the Pharmaceutical industry in Italy. July 2018
Facts&figures of the Pharmaceutical industry in Italy July 2018 Key figures of the Pharma sector in Italy Pharma industry in Italy by nationality of ownership (% on total) 40% Italian-owned companies 200
More informationPublic Consultation on a proposal for a mandatory Transparency Register
Case Id: 2963fe2f-f4f5-4f55-8698-bc26718599b0 Date: 01/06/2016 18:24:12 Public Consultation on a proposal for a mandatory Transparency Register Fields marked with are mandatory. Public Consultation on
More informationdelivering more You ll get more than just a delivery company with us, i.e. interlink express
delivering more You ll get more than just a delivery company with us, i.e. interlink express easier life We make it easy and efficient to integrate your organisation with ours Interlink Express has a range
More informationPhasing out nuclear power in Europe Rolf Golombek, Finn Roar Aune and Hilde Hallre Le Tissier 39th IAEE International Conference Bergen, June 2016
Oslo Centre of Research on Environmentally friendly Energy Phasing out nuclear power in Europe Rolf Golombek, Finn Roar Aune and Hilde Hallre Le Tissier 39th IAEE International Conference Bergen, June
More informationRENEWABLE H&C: BREAK-THROUGH NEEDS?
RENEWABLE H&C: BREAK-THROUGH NEEDS? Tobias Fleiter, Jan Steinbach, Fraunhofer ISI Brussels, 2017/10/17, EUFORES Based on 3 EU H&C projects Mapping and analyses of the H/C fuel deployment EC tender study
More informationAdEx Benchmark Study H1 2018
AdEx Benchmark Study H1 2018 November 2018 Digital Advertising in Europe The data and charts shown in this report cannot be used without the expressed permission of IAB Europe and IHS Markit All data and
More informationEuropean State Forest Association (EUSTAFOR) and Forest Certification Piotr Borkowski Executive Director
European State Forest Association (EUSTAFOR) and Forest Certification Piotr Borkowski Executive Director Presentation at Forest Certification in the State Forests (SF) current situation meeting on 20 April
More informationThe Fourth Community Innovation Survey (CIS IV)
The Fourth Community Innovation Survey (CIS IV) THE HARMONISED SURVEY QUESTIONNAIRE The Fourth Community Innovation Survey (Final Version: October 20 2004) This survey collects information about product
More informationto ensure that the public is properly informed about the state of the environment.
Contribution ID: 3d857566-b12a-41a3-b91d-7d9a03167ba4 Date: 20/10/2017 16:24:00 Public consultation to support the evaluation of the European Environment Agency (EEA) and its European Environment Information
More informationCancer survival trends and inequalities: what is the role for Europe?
Cancer survival trends and inequalities: what is the role for Europe? European Joint Action on Comprehensive Cancer Control 2014-2017 Brussels, Belgium, 13 May 2015 Measures of cancer burden definition
More informationDesigning a Talent Support Network ( ) Csilla Fuszek European Talent Centre - Budapest
Designing a Talent Support Network (2011-2018) Csilla Fuszek European Talent Centre - Budapest fuszekcs@gmail.com Presidential Conference on Talent Support Budapest - 2011 The idea of the European Talent
More informationPharmaceutical and Biotechnology Construction Sector Report - UK Analysis
Pharmaceutical and Biotechnology Construction Sector Report - UK 2016-2020 Analysis Published: 16/09/2016 / Number of Pages: 98 / Price: 795.00 Introduction and Overview The 3rd edition of the report'pharmaceutical
More informationDetailed Data from the 2010 OECD Survey on Public Procurement
ANNEX G Detailed Data from the 2010 OECD Survey on Public Procurement This annex provides data for each responding country on the transparency of the public procurement cycle, as well as the online availability
More informationDIRECT MAIL TRENDS IN EUROPE. Dr Sean Smyth
DIRECT MAIL TRENDS IN EUROPE Dr Sean Smyth Not another talk on Direct Mail Oh No! AGENDA The European advertising market Mail volumes addressed and door drops European direct mail print projections DM
More informationDisclosures and Acknowledgments
214 Cooperative Meeting of the Consortium of Multiple Sclerosis Centers and Americas Committee for Treatment and Research in Multiple Sclerosis Dallas, Texas DX1 Disability Progression in Multiple Sclerosis
More informationEurope s water in figures
Europe s water in figures An overview of the European drinking water and waste water sectors 2017 edition EurEau The European Federation of National Water Services Introduction EurEau is pleased to present
More informationPublic Relations Global Network CEO Interviews United Europe?
Public Relations Global Network CEO Interviews United Europe? An analysis of requirements and habits of European journalists - 14 European countries - 165 participants ---- Joint study of European PRGN
More informationThe European Commission s science and knowledge service. Joint Research Centre
The European Commission s science and knowledge service Joint Research Centre A modern JRC in a modern Commission Manuel Martín Ramos Euratom Coordination Tehran, 3 July, 2017 Society is facing many challenges
More informationPublic consultation on enhanced cooperation between Public Employment Services (PES)
Public consultation on enhanced cooperation between Public Employment Services (PES) Fields marked with * are mandatory. Introduction The European Network of Public Employment Services (PES Network) was
More informationCouncil of the European Union Brussels, 10 November 2016 (OR. en)
Conseil UE Council of the European Union Brussels, 10 November 2016 (OR. en) Interinstitutional File: 2016/0186 (COD) 13660/16 LIMITE NOTE CULT 101 AELE 77 EEE 41 CODEC 1506 From: Permanent Representatives
More informationHigh Potent Medicines Conference
2nd Annual High Potent Medicines Conference Looking beyond scale-up, containment, regulatory aspects and safety of highly potent compounds Event Overview The HPAPI industry is expanding at a healthy rate
More informationCelesio Policy Position
Celesio Policy Position Understanding the Value of Pharmaceutical Distribution February 2017 Background Pharmaceutical distributors are the backbone of national medicines supply, delivering swiftly the
More informationInternational Association of Hydrogeologists
International Association of Hydrogeologists Teodóra Szőcs International Association of Hydrogeologists Mining and Geological Survey of Hungary KINDRA Final Conference MAKING GROUNDWATER VISIBLE, ACCESSIBLE
More informationKellen Europe Introduction to lobbying in Brussels The EU decision makers The role of associations Coalition building National focus Conclusions
HOW BRUSSELS WORKS? CONTENT Kellen Europe Introduction to lobbying in Brussels The EU decision makers The role of associations Coalition building National focus Conclusions KELLEN EUROPE Formerly Ernst
More informationA European Public-Private Partnership! in Healthcare! Michel Goldman, MD,PhD Executive Director
A European Public-Private Partnership! in Healthcare! Michel Goldman, MD,PhD Executive Director ITMAT 2010, 27 October 2010 EFPIA Member Companies Participating companies (September 2010):! Innovative
More informationEuropean Deontological Recommendation
European Deontological Recommendation European Council of Medical Ordres Conseil Européen des Ordres des Médecins Dr. KERZMANN A.S. STURBOIS Dr. P. HECQUARD Dr. F. ALBERTI Working Group on Deontological
More information